Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B

NCT05618730 is registered in ClinicalTrials.gov with Eximore Ltd. as lead sponsor.

NCT NCT05618730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
Lead sponsor
Eximore Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
September 29, 2022
Completion date
December 30, 2023
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, keratoconjunctivitis sicca, ocular inflammation